TARDBP and Alzheimer disease: We also investigated associations between plasma biomarkers and the presence of co‐pathologies commonly observed in AD patients including cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), TDP‐43, cerebral white matter rarefaction (CWMR), and argyrophilic grain disease (AGD).